Editor Profile
Prof. Haidan Chen, M.D., Ph.D.
Director
Present
China Three Gorges University
Yichang
China
Haidan Chen, M.D., Ph.D., is Director of Spinal Surgery at the First Clinical Medical College of Three Gorges University and Yichang Central People’s Hospital. He oversees a 90-bed tertiary referral center performing more than 2,000 procedures annually, having established day surgery for osteoporotic vertebral compression fractures and full-endoscopic treatment of lumbar degenerative disorders. Funded by the National Natural Science Foundation of China and other grants, he has published over 30 peer-reviewed SCI papers on osteosarcoma immunity and endoscopic spinal surgery (H-index 11). Over 60 papers have been published in core Chinese journals.Dr. Chen serves on standing committees of multiple academic societies and as a young editorial board member for several journals, and has received honors including CNKI Highly Cited Scholar and the Yichang Youth Science & Technology Award.
- The research spans a broad range of areas, including basic studies in tumor immunology and molecular immunology, protein glycosylation in disease, early diagnosis and pathogenic mechanisms of spinal disorders, development of novel diagnostic and therapeutic strategies, as well as interdisciplinary medicine–engineering integration and translational clinical applications., as well as medical education research, etc.
- Spinal Tuberculosis
- Spinal Infections
- Diagnostic
- Protein Glycosylation and Immunity
- Drug Delivery Systems
- Clinical Translation
- Jia S, Chen Y, Zhuo C, Hu M, Zhang C,et al. Aptamer-modified melittin micelles efficiently inhibit osteosarcoma deterioration by inducing immunogenic cell death.[J].Colloids Surf B Biointerfaces,2025.
- Liu Z, Cai H, Wang T,et al. Gallic acid protect against spinal cord ischemia-reperfusion injury in rat via activation of Nrf2/HO-1 signaling.[J]. Regen Ther, 2025.
- Zhuo C, Liu Y, Zhang Y, et al. Comparison of the short-term efficacy of MIS-TLIF and Endo-LIF for the treatment of two-segment lumbar degenerative disease.[J]. BMC Musculoskelet Disord, 2024.
- Chen S, Yang D, Zhuo C, et al. Comparative analysis of percutaneous vertebroplasty and kyphoplasty in the treatment of Stage III Kummell's disease without neurological symptoms: a retrospective study[J]. J Orthop Surg Res, 2024.
- Liu Z, Cai H, Zhou Z, et al. Causal relationship between basal metabolic rate and intervertebral disc degeneration: a Mendelian randomization study[J]. Eur Spine J, 2024.
- Yang D, Chen S, Zhuo C, et al. Analysis of Risk Factors for Postoperative Deep Vein Thrombosis in Traumatic Spinal Fracture Complicated with Spinal Cord Injury[J]. Clin Appl Thromb Hemost, 2024.
- Tang L, Cegang F, Zhao H, et al. Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma Growth with Induction of IFN-γ Secretion and Proliferation of CD8(+) T Cells[J]. Curr Cancer Drug Targets, 2023.
- Han F, Liu F, Chen H, et al. Full-endoscopic Discectomy by interlaminar approach for a case of Idiopathic Spinal Epidural Lipomatosis[J]. Asian J Surg, 2023.
- Yu X, Jia S, Yu S, et al. Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies[J]. J Nanobiotechnology, 2023.
- Tang L, Fu CG, Zhou ZY, et al. Clinical Features and Outcomes of Spinal Tuberculosis in Central China[J]. Infect Drug Resist, 2022 .
- Fu C, Zhao H, Wang Y, et al. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen[J]. HLA, 2016.
- Chen HD, Zhou X, Yu G, et al. Knockdown of core 1 beta 1, 3-galactosyltransferase prolongs skin allograft survival with induction of galectin-1 secretion and suppression of CD8+ T cells: T synthase knockdown effects on galectin-1 and CD8+ T cells[J]. J Clin Immunol, 2012.
